Endoscopic Ultrasound System (EUS) Market Size, Share, Growth, and Industry Analysis, By Type (Endoscopy, Microprocessor, Ultrasound Probe), By Application (Hospital, Clinic, Other), Regional Insights and Forecast to 2034

Endoscopic Ultrasound System (EUS) Market Overview

The Endoscopic Ultrasound System (EUS) Market size was valued at USD 721.84 million in 2025 and is expected to reach USD 1143.15 million by 2034, growing at a CAGR of 5.3% from 2025 to 2034.

The Endoscopic Ultrasound System (EUS) Market is expanding due to increasing demand for minimally invasive diagnostic and therapeutic procedures in gastrointestinal and pulmonary diseases. Nearly 62% of gastrointestinal cancer diagnoses globally now utilize EUS technology for accurate staging and biopsy guidance. EUS systems provide imaging resolution up to 0.1–0.2 mm, enabling precise detection of tumors and lymph nodes. Around 58% of pancreatic cancer cases are diagnosed using EUS-guided procedures due to higher sensitivity compared to CT scans. The global healthcare sector performs over 1.5–2 million EUS procedures annually, with adoption increasing in early-stage cancer detection. Advanced EUS systems integrate Doppler imaging and elastography in nearly 42% of modern devices, improving diagnostic accuracy by 20–25% compared to conventional endoscopy methods.

In the United States, Endoscopic Ultrasound Systems are widely used across hospitals and specialized diagnostic centers, with over 75% of tertiary healthcare facilities equipped with EUS technology. Approximately 900,000–1.2 million EUS procedures are performed annually, primarily for gastrointestinal and pancreatic disease diagnosis. Nearly 65% of pancreatic cancer diagnoses rely on EUS-guided biopsy due to its high precision. Hospitals account for approximately 70% of total EUS usage, while clinics contribute around 25%. Advanced imaging technologies such as elastography and Doppler ultrasound are used in nearly 48% of EUS systems, improving diagnostic outcomes significantly.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:Approximately 68% of market growth is driven by rising demand for minimally invasive diagnostic procedures, improving early cancer detection rates by up to 30–40%.
• Major Market Restraint:Nearly 42% of healthcare facilities report high equipment costs, limiting adoption in small and mid-sized hospitals.
• Emerging Trends:Around 55% of new EUS systems now include elastography and Doppler imaging, while 33% adoption growth is seen in AI-assisted diagnostic tools.
• Regional Leadership:North America leads with nearly 36% market share, followed by Europe at 28%, driven by advanced healthcare infrastructure and early diagnosis programs.
• Competitive Landscape:Top five manufacturers control approximately 58% of global EUS system supply, focusing on high-resolution imaging and integrated diagnostic solutions.
• Market Segmentation:Endoscopy systems account for nearly 44% usage share, while hospital applications contribute approximately 68% of total demand globally.
• Recent Development:Between 2023–2025, nearly 47% of manufacturers introduced AI-assisted imaging systems, improving diagnostic accuracy by 20–25%.

Endoscopic Ultrasound System (EUS) Market Latest Trends

The Endoscopic Ultrasound System (EUS) Market is experiencing rapid advancements due to increasing demand for high-precision diagnostic imaging. Nearly 65% of new EUS systems now include high-frequency ultrasound probes, improving imaging resolution to detect lesions as small as 0.1 mm. Integration of elastography technology has increased by 42%, enabling better differentiation between benign and malignant tissues.AI-assisted diagnostic tools are emerging, with nearly 33% of new EUS systems incorporating machine learning algorithms for automated image analysis. These systems improve diagnostic efficiency by nearly 25–30% and reduce operator dependency.

Therapeutic EUS applications are also expanding, with nearly 28% of procedures involving interventional treatments, such as cyst drainage and tumor ablation. Demand for minimally invasive procedures is increasing, with nearly 70% of patients preferring EUS-guided diagnosis over surgical biopsy methods.Hospitals dominate usage, accounting for nearly 68% of procedures, while outpatient clinics contribute around 25%. Asia-Pacific is showing strong growth, with adoption increasing by 35% in recent years, driven by expanding healthcare infrastructure and rising cancer incidence rates.

Endoscopic Ultrasound System (EUS) Market Dynamics

DRIVER

Increasing Demand for Minimally Invasive Diagnostic Procedures

The primary driver of the Endoscopic Ultrasound System (EUS) Market is the rising demand for minimally invasive diagnostic and therapeutic procedures. Nearly 68% of gastrointestinal diagnostic procedures globally now prefer minimally invasive techniques due to reduced patient recovery time by 40–50% compared to traditional surgery. EUS technology allows accurate tumor detection with precision up to 0.1–0.2 mm, improving early diagnosis rates by 30–40%. Around 58% of pancreatic cancer diagnoses rely on EUS-guided biopsy due to its high sensitivity. Increasing global cancer incidence, exceeding 19 million cases annually, further drives demand for advanced diagnostic tools.

RESTRAINT

High Equipment and Operational Costs

A major restraint in the EUS market is the high cost of equipment and maintenance. Nearly 42% of small and mid-sized healthcare facilities report financial limitations in acquiring advanced EUS systems. Maintenance and operational costs can increase by 20–25% annually, particularly for high-frequency ultrasound probes and imaging components. Around 35% of hospitals in developing regions lack access to EUS technology, limiting adoption. Additionally, specialized training is required for operators in nearly 50% of installations, increasing workforce development costs.

OPPORTUNITY

Expansion of Cancer Screening Programs

The expansion of global cancer screening programs presents a major opportunity, with nearly 60% of healthcare systems increasing investment in early detection technologies. EUS is widely used in gastrointestinal cancer screening, with adoption increasing by 35–40% in recent years. Government initiatives in over 50 countries are promoting early cancer diagnosis, increasing demand for advanced imaging systems. Nearly 45% of new diagnostic centers are integrating EUS technology to improve diagnostic accuracy and patient outcomes.

CHALLENGE

Limited Skilled Professionals

A key challenge in the EUS market is the shortage of skilled professionals trained in advanced endoscopic procedures. Nearly 38% of healthcare facilities report insufficient trained specialists, affecting system utilization rates. Training programs require 6–12 months of specialized education, limiting rapid workforce expansion. Around 30% of installed EUS systems operate below full capacity due to lack of expertise. Additionally, procedural complexity increases risk of complications in nearly 5–8% of cases, requiring highly skilled operators.

• 

  Download Free sample to learn more about this report.

Segmentation Analysis

The Endoscopic Ultrasound System (EUS) Market is segmented by type and application, with increasing demand driven by gastrointestinal diagnostics, oncology procedures, and minimally invasive imaging technologies. Globally, diagnostic applications account for nearly 72% of total EUS procedures, while therapeutic applications contribute around 28%, reflecting expanding interventional use. Hospitals dominate the application segment with approximately 68–70% share, followed by clinics at 20–25%. Among types, endoscopy-based EUS systems lead with around 44% share, followed by ultrasound probe systems and microprocessor-based platforms. Increasing integration of advanced imaging technologies is reshaping segmentation dynamics across all categories.

By Type

Endoscopy

Endoscopy-based EUS systems account for approximately 42–45% of the global market share, making them the most widely used type. These systems combine endoscopic visualization with ultrasound imaging, enabling real-time tissue assessment and biopsy guidance. Nearly 68% of gastrointestinal diagnostic procedures rely on endoscopic EUS systems due to their high precision. These systems can detect lesions as small as 0.1–0.2 mm, improving early cancer detection rates by nearly 30–40%. Adoption is particularly high in hospitals, where over 72% of EUS procedures use endoscopy-based systems. Integration with elastography and Doppler imaging is present in nearly 48% of modern devices, enhancing diagnostic capabilities.

Microprocessor

Microprocessor-based EUS systems represent approximately 25–28% of the market share, driven by advancements in digital imaging and data processing capabilities. These systems enable high-speed image processing, improving diagnostic accuracy by nearly 20–25%. Around 52% of newly installed EUS systems incorporate advanced microprocessor units to support real-time imaging and data analysis. These systems also enable integration with AI-based diagnostic tools, which are present in nearly 33% of modern installations. Microprocessor-based systems improve workflow efficiency by nearly 18–22%, reducing procedure time and enhancing clinical outcomes.

Ultrasound Probe

Ultrasound probe systems account for approximately 27–30% of the global market share, playing a critical role in high-frequency imaging and tissue characterization. These probes operate at frequencies ranging from 5 MHz to 20 MHz, enabling detailed imaging of internal organs and structures. Nearly 58% of pancreatic cancer diagnoses rely on high-frequency ultrasound probes for accurate staging. Advanced probe technologies, including linear and radial probes, are used in nearly 62% of EUS procedures, providing versatility in diagnostic and therapeutic applications. Adoption of disposable and sterilizable probes has increased by 22% in recent years, improving infection control and patient safety.

By Application

Hospital

Hospitals dominate the Endoscopic Ultrasound System (EUS) Market with approximately 68–70% share, driven by high patient volume and advanced diagnostic infrastructure. Nearly 75% of tertiary healthcare facilities globally are equipped with EUS systems, performing over 1.2–1.5 million procedures annually. Hospitals are the primary centers for complex diagnostic and therapeutic procedures, including cancer staging and interventional EUS. Around 65% of pancreatic cancer diagnoses are conducted in hospital settings using EUS technology. Advanced imaging features such as elastography and Doppler ultrasound are used in nearly 50% of hospital-based systems, improving diagnostic accuracy significantly.

Clinic

Clinics account for approximately 20–25% of the market share, primarily focused on outpatient diagnostic procedures and early-stage disease detection. Nearly 45% of gastrointestinal diagnostic procedures in urban areas are performed in clinics using EUS systems. These facilities typically use compact and cost-efficient EUS systems, supporting procedure volumes of 200–500 cases annually per clinic. Adoption of EUS in clinics has increased by 28–32% in recent years, driven by demand for minimally invasive diagnostics and reduced hospital burden. Clinics also contribute to nearly 35% of routine cancer screening procedures in developed regions.

Other Applications

Other applications, including research institutes, ambulatory surgical centers, and specialty diagnostic facilities, account for approximately 5–8% of the market share. Nearly 38% of clinical research studies in gastroenterology utilize EUS systems for data collection and analysis. Ambulatory surgical centers perform nearly 15–20% of interventional EUS procedures, particularly in minimally invasive treatments. Adoption in this segment has increased by 22–25%, driven by expansion of specialized healthcare services and research activities. These facilities play a key role in advancing EUS technology and improving procedural outcomes.

• 

  Download Free sampleto learn more about this report.

Regional Outlook

North America

North America dominates the Endoscopic Ultrasound System (EUS) Market with approximately 34–36% share, driven by advanced healthcare infrastructure and high adoption of minimally invasive diagnostic procedures. The United States accounts for nearly 80% of regional demand, with over 75% of hospitals equipped with EUS systems. Nearly 1 million EUS procedures are performed annually in the region, primarily for gastrointestinal and pancreatic disease diagnosis.Hospitals dominate usage, accounting for nearly 70% of procedures, while clinics contribute around 25%. Advanced imaging technologies such as elastography and Doppler ultrasound are used in nearly 52% of EUS systems, improving diagnostic accuracy by 20–25%. Cancer screening programs are well established, with nearly 65% of pancreatic cancer diagnoses relying on EUS-guided biopsy.

Adoption of AI-based diagnostic tools is increasing, with nearly 35% of new installations incorporating machine learning algorithms. These systems improve efficiency by nearly 25–30% and reduce diagnostic errors. Additionally, healthcare expenditure in the region supports technological advancements, with nearly 48% of facilities upgrading to next-generation EUS systems.

Europe

Europe holds approximately 26–28% of the global market share, supported by strong healthcare systems and early diagnosis initiatives. Countries such as Germany, France, and the United Kingdom contribute nearly 70% of regional demand. Nearly 68% of hospitals in Western Europe use EUS systems for gastrointestinal diagnostics.Cancer screening programs are a key driver, with nearly 60% of gastrointestinal cancer cases diagnosed using EUS technology. Hospitals account for approximately 65% of usage, while clinics contribute around 25%. Adoption of advanced imaging technologies is increasing, with nearly 45% of systems incorporating elastography and Doppler features.

The region is also focusing on minimally invasive procedures, with nearly 72% of patients preferring EUS-based diagnosis over surgical biopsy methods. Technological advancements are supported by healthcare policies, with nearly 40% of facilities upgrading imaging systems in recent years. Research and development activities are strong, with nearly 30% of clinical trials involving EUS technology.

Asia-Pacific

Asia-Pacific accounts for approximately 30–32% of the global market share, making it one of the fastest-growing regions. China, India, and Japan collectively contribute nearly 65% of regional demand. Nearly 55% of hospitals in major urban centers are equipped with EUS systems, with adoption increasing rapidly.Rising cancer incidence is a major driver, with nearly 50% of gastrointestinal cancer cases diagnosed using EUS technology in advanced healthcare facilities. Hospitals dominate with approximately 68% share, while clinics contribute around 22%. Adoption has increased by 35% in recent years, driven by healthcare infrastructure expansion.

Government initiatives in over 40 countries are promoting early cancer detection, increasing demand for EUS systems. Technological advancements are also rising, with nearly 38% of new installations featuring AI-based imaging tools. Additionally, medical tourism contributes to nearly 20% of EUS procedures in the region, particularly in countries with advanced healthcare services.

Middle East & Africa

Middle East & Africa account for approximately 6–8% of the global market share, with steady growth driven by improving healthcare infrastructure. GCC countries contribute nearly 60% of regional demand, particularly in UAE and Saudi Arabia. Nearly 48% of hospitals in urban areas are equipped with EUS systems, with adoption increasing by 20–25% annually.Hospitals dominate with approximately 70% share, while clinics contribute around 20%. Cancer diagnosis is a key application, with nearly 55% of gastrointestinal cancer cases utilizing EUS technology. Healthcare investments are increasing, with nearly 35% of facilities upgrading diagnostic equipment.

Challenges remain in rural areas, where access to advanced healthcare is limited. However, urban healthcare expansion and medical tourism are driving adoption. Nearly 18% of patients in the region travel internationally for advanced diagnostic procedures, including EUS.

List of Top Endoscopic Ultrasound System (EUS) Companies

• Olympus Corporation
• Hitachi Medical Systems
• PENTAX Medical
• Fujifilm
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

Top 2 Companies by Market Share

Olympus Corporation:Olympus Corporation holds approximately 28–32% global market share, making it the leading player in the Endoscopic Ultrasound System (EUS) Market. The company supplies EUS systems to over 120 countries, with nearly 65% of tertiary hospitals globally using Olympus endoscopy systems. Its EUS platforms offer imaging resolution up to 0.1 mm, improving early cancer detection rates by 30–40%. Around 55% of its product portfolio includes advanced elastography and Doppler imaging features, enhancing diagnostic accuracy by 20–25%. Olympus systems are used in nearly 60% of gastrointestinal cancer diagnostic procedures worldwide.

Fujifilm:Fujifilm accounts for approximately 18–22% global market share, with strong presence in Asia-Pacific and Europe. The company’s EUS systems are deployed in over 90 countries, supporting nearly 45% of advanced diagnostic centers. Fujifilm systems incorporate high-frequency ultrasound probes operating up to 20 MHz, improving tissue imaging clarity by 25–30%. Nearly 48% of its systems include AI-assisted imaging capabilities, enhancing workflow efficiency by 20–25%. Adoption of Fujifilm EUS systems has increased by 28% in the last few years, particularly in emerging healthcare markets.

Investment Analysis and Opportunities

The Endoscopic Ultrasound System (EUS) Market presents strong investment opportunities driven by increasing demand for early cancer diagnosis and minimally invasive procedures. Nearly 62% of global healthcare investments in diagnostic imaging are directed toward advanced imaging technologies, including EUS systems. Investment in AI-assisted diagnostic tools has increased by 40–45%, improving imaging accuracy by 20–30%.Hospitals account for nearly 70% of total system procurement, making them the primary investment focus.

Emerging markets in Asia-Pacific represent approximately 35% of new investment opportunities, driven by expanding healthcare infrastructure and rising disease prevalence. Nearly 45% of new diagnostic centers are integrating EUS systems to enhance diagnostic capabilities.Technological advancements such as elastography and Doppler imaging are included in nearly 50% of new systems, attracting investment in innovation-driven companies. Additionally, outpatient diagnostic centers are growing, with nearly 30% of investments directed toward clinics and ambulatory facilities. Increasing adoption of minimally invasive procedures, preferred by nearly 70% of patients, further strengthens market investment potential.

New Product Development

Innovation in the Endoscopic Ultrasound System (EUS) Market is focused on improving imaging accuracy, workflow efficiency, and patient outcomes. Nearly 58% of new EUS systems now include high-frequency ultrasound probes, enabling detection of lesions as small as 0.1 mm. Elastography technology is integrated into approximately 45% of new devices, improving differentiation between benign and malignant tissues by 25–30%.AI-based imaging systems are emerging rapidly, with nearly 33–38% of new product launches incorporating machine learning algorithms for automated diagnosis.

These systems reduce diagnostic time by 20–25% and improve accuracy significantly. Additionally, portable EUS systems are being developed, accounting for nearly 22% of new innovations, enabling use in smaller clinics and remote healthcare settings.Integration with digital healthcare systems is increasing, with nearly 40% of new EUS devices featuring cloud-based data management, improving workflow efficiency and data accessibility. Disposable ultrasound probes are also gaining adoption, representing nearly 18–22% of new product developments, improving infection control standards.

Five Recent Developments (2023–2025)

1. In 2023, over 45% of manufacturers introduced AI-assisted EUS systems, improving diagnostic accuracy by 20–25%.
2. In 2023, adoption of elastography-enabled EUS systems increased by 30% globally in cancer diagnosis applications.
3. In 2024, portable EUS devices expanded by 25% in outpatient and clinic settings, improving accessibility.
4. In 2024, high-frequency ultrasound probes operating above 15 MHz were integrated into 50% of new systems, enhancing imaging clarity.
5. In 2025, digital integration with cloud-based platforms increased by 38% across healthcare facilities, improving data management and workflow efficiency.

Report Coverage of Endoscopic Ultrasound System (EUS) Market

The Endoscopic Ultrasound System (EUS) Market report provides comprehensive coverage of global industry trends, segmentation, regional insights, and technological advancements. The market issegmented by type into endoscopy (42–45% share), microprocessor (25–28% share), and ultrasound probe systems (27–30% share), reflecting diverse technological applications.Application analysis includes hospitals (68–70% share), clinics (20–25% share), and other facilities (5–8% share), highlighting the dominance of hospital-based diagnostic procedures. Regional coverage includes North America (34–36% share), Europe (26–28% share), Asia-Pacific (30–32% share), and Middle East & Africa (6–8% share), reflecting global adoption patterns.

The report evaluates over 10 major global manufacturers, with the top two companies controlling approximately 45–50% of total market supply. Technological advancements such as AI-based imaging, elastography, and high-frequency ultrasound probes are analyzed in detail, with adoption rates increasing by 30–50% across modern systems.Investment trends highlight strong growth in diagnostic imaging technologies, with nearly 60% of healthcare investments focusing on early disease detection systems. The report also examines operational efficiency improvements, where EUS systems enhance diagnostic accuracy by 20–30% and reduce patient recovery time by 40–50% compared to invasive procedures.